Infant and maternal characteristics in neonatal abstinence syndrome-selected hospitals in Florida, 2010-2011

Morbidity and Mortality Weekly Report

Volumn 64, Issue 8, 2015, Pages 213-216

  Lind, Jennifer N ^a,b,c   Petersen, Emily E ^a,b,c   Lederer, Philip A ^a,c   Phillips Bell, Ghasi S ^b,d   Perrine, Cria G ^b,c   Li, Ruowei ^b   Hudak, Mark ^e   Correia, Jane A ^d   Creanga, Andreea A ^b   Sappenfield, William M ^f   Curran, John ^g   Blackmore, Carina ^d   Watkins, Sharon M ^d   Anjohrin, Suzanne ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c United States Public Health Service Commissioned Corps   (United States)

^d FLORIDA DEPARTMENT OF HEALTH   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; NARCOTIC ANALGESIC AGENT;

ADULT; BREAST FEEDING; CHRONIC PAIN; COMORBIDITY; EPIDEMIOLOGY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOW BIRTH WEIGHT; MATERNAL AGE; NEONATAL ABSTINENCE SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURITY; PRENATAL EXPOSURE; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; SURVIVAL RATE; TOBACCO; UNITED STATES; UTILIZATION;

ADULT; ANALGESICS, OPIOID; BENZODIAZEPINES; BREAST FEEDING; CANNABIS; CAUSALITY; CHRONIC PAIN; COCAINE; COMORBIDITY; FEMALE; FLORIDA; HOSPITALIZATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; MATERNAL AGE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS; SURVIVAL RATE; TOBACCO;

EID: 84924358627     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hudak ML, Tan RC, Committee On Drugs, Committee On Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012;129:e540-60.
2. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012;307:1934-40.
3. Zimmermann-Baer U, Notzli U, Rentsch K, Bucher HU. Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction 2010;105:524-8.
4. Creanga AA, Sabel JC, Ko JY, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol 2012;119:924-33.
5. CDC. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999-2010. MMWR Morb Mortal Wkly Rep 2013;62:537-42.
6. Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis 2010;29:127-38.
7. Committee on Health Care for Underserved Women and the American Society of Addiction Medicine. Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Washington, DC: American Congress of Obstetricians and Gynecologists; 2012. Available at http://www.acog.org/resources-and-publications/committee-opinions/committee-on-health-care-for-underserved-women/opioid-abuse-dependence-and-addiction-in-pregnancy.
8. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006;117:e1163-9.
9. Isemann B, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol 2011;31:25-9.
10. Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarko L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica 2013;102:1060-6.